Science news

Curis Announces Encouraging Emavusertib Data at the 2022 American Society of Clinical Oncology Annual Meeting (ASCO)

TakeAim Lymphoma data for the combination of emavusertib plus ibrutinib show tumor reduction in 8 of 9 evaluable patients, including 2 complete responses and...

Global Blood Glucose Monitoring Devices Market (2022 to 2030) – Size, Share & Trends Analysis Report

DUBLIN, June 3, 2022 /PRNewswire/ -- The "Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report by Product (Self-Monitoring Devices, Continuous Blood...

Medline introduces enhanced Optifoam Gentle EX foam dressing to help pressure injury prevention

Healthcare company to unveil latest addition to Skin Health Solution Program at 2022 WOCNext conference NORTHFIELD, Ill., June 2, 2022 /PRNewswire/ -- Medline today announced...

NJ Top Doc, Dr. Paul Abend Continues To Receive Awards For His Work With Autism

Paul Abenda, DO has been reviewed and approved by NJ Top Docs for 2022. This Top Doctor has been making notable contributions to the...

Research Reveals Secrets of Baffling but All-Too-Common Type of Diabetes

BRONX, N.Y., June 2, 2022 /PRNewswire/ -- A mysterious form of diabetes known as malnutrition-related diabetes afflicts tens of millions of people in Asian...

Aeglea BioTherapeutics Receives Refusal to File Letter from FDA for Pegzilarginase for the Treatment of Arginase 1 Deficiency

AUSTIN, Texas, June 2, 2022 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics...

Latest articles